Table 2.
Progression-free rate (24 weeks and 48 weeks).
| Judged by the local investigators | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Group | Term (weeks) | n | Response | Progression free rate | p | ||||
| CR | PR | SD | PD | n (%) | 95%CI | ||||
| Z | 24 | 20 | 0 | 1 | 18 | 1 | 19 (95%) | 75.1- 99.9 | 1.000 (Z24 vs P24) |
| 48 | 17 | 0 | 1 | 15 | 1 | 16 (94.1%) | 71.3-99.9 | 0.486 (Z48 vs P48) | |
| P | 24 | 19 | 0 | 0 | 19 | 0 | 19 (100%) | 82.4-100.0 | |
| 48 | 18 | 0 | 1 | 17 | 0 | 18 (100%) | 81.5-100.0 | ||
| Judged by the central committee radiologist | |||||||||
| Group | Term (weeks) | n | Response | Progression free rate | p | ||||
| CR | PR | SD | PD | n (%) | 95%CI | ||||
| Z | 24 48 |
20 | 0 | 1 | 18 | 1 | 19 (95%) | 75.1 - 99.9 | 1.000 (Z24 vs P24) |
| 17 | 0 | 1 | 16 | 0 | 17 (100%) | 80.5- 100.0 | 0.229 (Z48 vs P48) | ||
| P | 24 48 |
19 | 0 | 0 | 18 | 1 | 18 (94.7%) | 74.0 - 99.9 | |
| 18 | 0 | 0 | 15 | 3 | 15 (83.3%) | 58.6 - 96.4 | |||
CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.